Abstract
We describe the case of a boy who presented with abdominal Burkitt lymphoma; he had been regularly using tacrolimus ointment 0.1% for severe recurrent atopic dermatitis for 7 years immediately prior to developing cancer. We present his medical history and review the current knowledge regarding a link between topical tacrolimus and malignancy risk.
MeSH terms
-
Administration, Cutaneous
-
Burkitt Lymphoma / chemically induced
-
Burkitt Lymphoma / complications
-
Burkitt Lymphoma / diagnosis*
-
Burkitt Lymphoma / surgery
-
Child
-
Dermatitis, Atopic / complications
-
Dermatitis, Atopic / drug therapy*
-
Diagnosis, Differential
-
Humans
-
Ileal Diseases / complications
-
Ileal Diseases / diagnosis
-
Ileal Diseases / surgery
-
Ileal Neoplasms / chemically induced
-
Ileal Neoplasms / complications
-
Ileal Neoplasms / diagnosis*
-
Ileal Neoplasms / surgery
-
Ileocecal Valve* / surgery
-
Immunosuppressive Agents / administration & dosage
-
Immunosuppressive Agents / adverse effects*
-
Intussusception / complications
-
Intussusception / diagnosis
-
Intussusception / surgery
-
Male
-
Tacrolimus / administration & dosage
-
Tacrolimus / adverse effects*
-
Tomography, X-Ray Computed
Substances
-
Immunosuppressive Agents
-
Tacrolimus